{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:11:59Z","timestamp":1789690319039,"version":"4.0.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ncrna.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:28:08Z","timestamp":1785338888000},"page":"72-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A DNA Tetrahedron\u2013Delivered miR-17-5p mimic exerts dual anti-inflammatory and Anti-Pseudomonas aeruginosa effects in cystic fibrosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Yunfei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1240-1825","authenticated-orcid":false,"given":"YinHeRichard","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4787-8262","authenticated-orcid":false,"given":"Hawraa","family":"Shahrour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Oglesby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-2569","authenticated-orcid":false,"given":"Catherine M.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncrna.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-017-1193-9","article-title":"Cystic fibrosis: current therapeutic targets and future approaches","volume":"15","author":"Rafeeq","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ncrna.2026.06.006_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2021.23280","article-title":"What is cystic fibrosis?","volume":"327","author":"Endres","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ncrna.2026.06.006_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ncrna.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acsptsci.9b00060","article-title":"Emerging cystic fibrosis transmembrane conductance regulator modulators as new drugs for cystic fibrosis: a portrait of in vitro pharmacology and clinical translation","volume":"3","author":"Ghelani","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ncrna.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.00146807","article-title":"Inhibition of airway proteases in cystic fibrosis lung disease","volume":"32","author":"Griese","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ncrna.2026.06.006_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ncrna.2026.06.006_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fcimb.2017.00039","article-title":"Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence","volume":"7","author":"Moradali","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib8","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ncrna.2026.06.006_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0300985813502820","article-title":"MicroRNAs: history, biogenesis, and their evolving role in animal development and disease","volume":"51","author":"Bhaskaran","year":"2014","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib10","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4049\/jimmunol.0902669","article-title":"miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression","volume":"184","author":"Oglesby","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00161-2018","article-title":"Nebulised lipid-polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells","volume":"5","author":"Vencken","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ncrna.2026.06.006_bib12","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1183\/09031936.00163414","article-title":"miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production","volume":"46","author":"Oglesby","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ncrna.2026.06.006_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105370118","article-title":"Let-7b-5p in vesicles secreted by human airway cells reduces biofilm formation and increases antibiotic sensitivity of P. aeruginosa","volume":"118","author":"Koeppen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.ncrna.2026.06.006_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000549134","article-title":"Target-based biofilm inhibition and antibiotic enhancement strategy by MiR.101.3p using DNA tetrahedrons","volume":"17","author":"Sun","year":"2025","journal-title":"J. Innate Immun"},{"key":"10.1016\/j.ncrna.2026.06.006_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/17460913.2024.2357971","article-title":"microRNAs: a new class of endogenous antimicrobials for the treatment of infections in cystic fibrosis and beyond","volume":"19","author":"Ye","year":"2024","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.70114","article-title":"Extracellular particles derived from mesenchymal stromal cells reduce Pseudomonas aeruginosa lung infection and inflammation in mice","volume":"5","author":"Sarkar","year":"2026","journal-title":"J Extracell Biol"},{"key":"10.1016\/j.ncrna.2026.06.006_bib17","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00353.2025","article-title":"MicroRNA-Enriched EVs from mesenchymal stromal cells: a novel approach to suppress biofilm and inflammation in CF airway epithelium","author":"Raghubansi","year":"2026","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib18","doi-asserted-by":"crossref","first-page":"L455","DOI":"10.1152\/ajplung.00187.2025","article-title":"Mesenchymal stromal cell extracellular vesicles reduce pseudomonas biofilm formation, and let-7b-5p loading confers additional anti-inflammatory effects","volume":"329","author":"Sarkar","year":"2025","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib19","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1128\/JB.184.19.5457-5467.2002","article-title":"sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4","volume":"184","author":"Horsburgh","year":"2002","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/JCM.02280-06","article-title":"Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections","volume":"45","author":"O'Neill","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.gt.3301741","article-title":"Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-Mediated targeting","volume":"9","author":"Bruscia","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.ncrna.2026.06.006_bib22","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.1120367","article-title":"Rapid chiral assembly of rigid DNA building blocks for molecular nanofabrication","volume":"310","author":"Goodman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ncrna.2026.06.006_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12951-020-00667-6","article-title":"Loop-armed DNA tetrahedron nanoparticles for delivering antisense oligos into bacteria","volume":"18","author":"Hu","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00653-23","article-title":"Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development","volume":"8","author":"Neff","year":"2023","journal-title":"mSystems"},{"key":"10.1016\/j.ncrna.2026.06.006_bib25","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/acscentsci.0c00763","article-title":"Kidney-targeted cytosolic delivery of siRNA using a small-sized mirror DNA tetrahedron for enhanced potency","volume":"6","author":"Thai","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ncrna.2026.06.006_bib26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/acschembio.5b01082","article-title":"Chemical inhibition of kynureninase reduces Pseudomonas aeruginosa quorum sensing and virulence factor expression","volume":"11","author":"Kasper","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib27","doi-asserted-by":"crossref","first-page":"W435","DOI":"10.1093\/nar\/gkx279","article-title":"IntaRNA 2.0: enhanced and customizable prediction of RNA-RNA interactions","volume":"45","author":"Mann","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ncrna.2026.06.006_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063128","article-title":"Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors","volume":"22","author":"Jurado-Martin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2026.06.006_bib29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ncrna.2026.06.006_bib30","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1128\/AAC.03644-14","article-title":"Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents","volume":"58","author":"Papadopoulou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ncrna.2026.06.006_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107527","article-title":"A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa","volume":"66","author":"Hardie Boys","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ncrna.2026.06.006_bib32","first-page":"1","article-title":"Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator","volume":"73","author":"Balasubramanian","year":"2015","journal-title":"Pathog Dis"},{"key":"10.1016\/j.ncrna.2026.06.006_bib33","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1128\/AAC.00009-10","article-title":"ampG gene of Pseudomonas aeruginosa and its role in beta-lactamase expression","volume":"54","author":"Zhang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ncrna.2026.06.006_bib34","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2217\/fmb.10.125","article-title":"Pseudomonas aeruginosa biofilms in cystic fibrosis","volume":"5","author":"H\u00f8iby","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.prrv.2010.05.003","article-title":"Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis","volume":"11","author":"Stuart","year":"2010","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.ncrna.2026.06.006_bib36","article-title":"Polymicrobial interactions in the cystic fibrosis airway microbiome impact the antimicrobial susceptibility of Pseudomonas aeruginosa","volume":"10","author":"Reece","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ncrna.2026.06.006_bib37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/423821","article-title":"Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis","volume":"190","author":"Rogan","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ncrna.2026.06.006_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.micpath.2017.10.017","article-title":"Serine\/Threonine protein kinase PpkA contributes to the adaptation and virulence in Pseudomonas aeruginosa","volume":"113","author":"Pan","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ncrna.2026.06.006_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12866-015-0392-x","article-title":"Extracellular ATP inhibits twitching motility-mediated biofilm expansion by Pseudomonas aeruginosa","volume":"15","author":"Nolan","year":"2015","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib40","article-title":"Prevalence of the genes associated with biofilm and toxins synthesis amongst the Pseudomonas aeruginosa clinical strains","volume":"10","author":"Bogiel","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ncrna.2026.06.006_bib41","article-title":"Myricetin potentiates antibiotics against resistant Pseudomonas aeruginosa by disrupting biofilm formation and inhibiting motility through FimX-Mediated c-di-GMP signaling interference","volume":"14","author":"Zeng","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.ncrna.2026.06.006_bib42","first-page":"363","article-title":"Association between biofilm formation and antimicrobial resistance in carbapenem-resistant Pseudomonas aeruginosa","volume":"48","author":"Cho","year":"2018","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.ncrna.2026.06.006_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/17476348.2022.2100350","article-title":"Epithelial damage in the cystic fibrosis lung: the role of host and microbial factors","volume":"16","author":"Glasgow","year":"2022","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.ncrna.2026.06.006_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","article-title":"Inflammation in cystic fibrosis lung disease: pathogenesis and therapy","volume":"14","author":"Cantin","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ncrna.2026.06.006_bib45","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ncrna.2026.06.006_bib46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ncrna.2026.06.006_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1753465816680573","article-title":"Best practices in the treatment of early cystic fibrosis lung disease","volume":"11","author":"Proesmans","year":"2017","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.ncrna.2026.06.006_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176379","article-title":"Airway inflammation and host responses in the era of CFTR modulators","volume":"21","author":"Keown","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2026.06.006_bib49","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1021\/nn2005574","article-title":"DNA cage delivery to Mammalian cells","volume":"5","author":"Walsh","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.ncrna.2026.06.006_bib50","article-title":"Biomimetic Nanoerythrosome-Coated Aptamer-DNA tetrahedron\/maytansine conjugates: ph-responsive and targeted cytotoxicity for HER2-Positive breast cancer","volume":"34","author":"Ma","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ncrna.2026.06.006_bib51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nnano.2012.73","article-title":"Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery","volume":"7","author":"Lee","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib52","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1039\/C9CC00175A","article-title":"DNA tetrahedron-based nanogels for siRNA delivery and gene silencing","volume":"55","author":"Xue","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ncrna.2026.06.006_bib53","article-title":"Programmable tetrahedral DNA-RNA nanocages woven with stimuli-responsive siRNA for enhancing therapeutic efficacy of multidrug-resistant tumors","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ncrna.2026.06.006_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41596-024-01050-7","article-title":"A bioswitchable delivery system for microRNA therapeutics based on a tetrahedral DNA nanostructure","volume":"20","author":"Li","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ncrna.2026.06.006_bib55","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1021\/jacsau.5c00549","article-title":"Tetrahedron DNA nanostructures as microRNA inhibitors to alleviate acute pancreatitis","volume":"5","author":"Li","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.ncrna.2026.06.006_bib56","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1111\/cas.14548","article-title":"Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy","volume":"111","author":"Duangrat","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ncrna.2026.06.006_bib57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12951-021-01164-0","article-title":"Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects","volume":"19","author":"Yan","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib58","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1574888X15666200422103415","article-title":"The application of tetrahedral framework nucleic acids as a drug carrier in biomedicine fields","volume":"16","author":"Zhang","year":"2021","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.ncrna.2026.06.006_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13071527","article-title":"Biofilm formation of Pseudomonas aeruginosa in cystic fibrosis: mechanisms of persistence, adaptation, and pathogenesis","volume":"13","author":"Borisova","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.ncrna.2026.06.006_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12112115","article-title":"Pseudomonas aeruginosa in the frontline of the greatest challenge of biofilm infection-its tolerance to antibiotics","volume":"12","author":"Hoiby","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ncrna.2026.06.006_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.625597","article-title":"Immune responses to Pseudomonas aeruginosa biofilm infections","volume":"12","author":"Moser","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.851784","article-title":"Pseudomonas aeruginosa is more tolerant under biofilm than under planktonic growth conditions: a multi-isolate survey","volume":"12","author":"Thoming","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41522-025-00869-6","article-title":"Beyond the matrix: rethinking antibiotic tolerance in CF biofilms using 3D models","volume":"12","author":"Osondu-Chuka","year":"2025","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.ncrna.2026.06.006_bib64","article-title":"Antibiotic resistance in patients with cystic fibrosis: past, present, and future","volume":"12","author":"Perikleous","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ncrna.2026.06.006_bib65","article-title":"Resistance of Pseudomonas aeruginosa to antibiotics during long-term persistence in patients with cystic fibrosis","volume":"14","author":"Belkova","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ncrna.2026.06.006_bib66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ncrna.2026.06.006_bib67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: an emergent form of bacterial life","volume":"14","author":"Flemming","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30684","article-title":"In silico hybridization and molecular dynamics simulations for the identification of candidate human MicroRNAs for inhibition of virulent proteins' expression in Staphylococcus aureus","volume":"126","author":"Tiwari","year":"2025","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ncrna.2026.06.006_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1009901","article-title":"microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection","volume":"12","author":"Davuluri","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib70","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s11658-022-00368-y","article-title":"The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges","volume":"27","author":"Zhang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ncrna.2026.06.006_bib71","article-title":"Tiny but mighty: small RNAs-The micromanagers of bacterial survival, virulence, and host-pathogen interactions","volume":"11","author":"Banerjee","year":"2025","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.ncrna.2026.06.006_bib72","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1021\/acsptsci.4c00308","article-title":"Adoption of a tetrahedral DNA nanostructure as a multifunctional biomaterial for drug delivery","volume":"7","author":"Huang","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ncrna.2026.06.006_bib73","first-page":"279","article-title":"DNA tetrahedral nanostructures for the biomedical application and spatial orientation of biomolecules","volume":"33","author":"Wang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ncrna.2026.06.006_bib74","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1021\/acsami.1c14975","article-title":"Hybrid lipid\/polymer nanoparticles to tackle the cystic fibrosis mucus barrier in siRNA delivery to the lungs: does PEGylation make the difference?","volume":"14","author":"Conte","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ncrna.2026.06.006_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12070616","article-title":"Cystic fibrosis: overview of the current development trends and innovative therapeutic strategies","volume":"12","author":"Almughem","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ncrna.2026.06.006_bib76","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2016.182","article-title":"The mucus barrier to inhaled gene therapy","volume":"24","author":"Duncan","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ncrna.2026.06.006_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17476348.2024.2323189","article-title":"Why don't anti-inflammatories work in cystic fibrosis?","volume":"18","author":"Casey","year":"2024","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.ncrna.2026.06.006_bib78","first-page":"CD008037","article-title":"Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis","volume":"2013","author":"Hurley","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ncrna.2026.06.006_bib79","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ymthe.2020.02.001","article-title":"Precise targeting of miRNA sites restores CFTR activity in CF bronchial epithelial cells","volume":"28","author":"De Santi","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ncrna.2026.06.006_bib80","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ncrna.2026.06.006_bib81","first-page":"500","article-title":"CFTR modulators for the treatment of cystic fibrosis","volume":"39","author":"Pettit","year":"2014","journal-title":"P T"},{"key":"10.1016\/j.ncrna.2026.06.006_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071243","article-title":"CFTR modulator therapies: potential impact on airway infections in cystic fibrosis","volume":"11","author":"Saluzzo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ncrna.2026.06.006_bib83","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(15)00201-5","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial","volume":"3","author":"Moss","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ncrna.2026.06.006_bib84","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.pupt.2006.08.008","article-title":"Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics","volume":"20","author":"Broughton-Head","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ncrna.2026.06.006_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.actbio.2025.07.068","article-title":"Inhalable nucleic acid therapeutics for chronic pulmonary disease: progress, challenges, and prospects","volume":"204","author":"Wang","year":"2025","journal-title":"Acta Biomater."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054026000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054026000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:39:23Z","timestamp":1789688363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054026000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":85,"alternative-id":["S2468054026000491"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2026.06.006","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A DNA Tetrahedron\u2013Delivered miR-17-5p mimic exerts dual anti-inflammatory and Anti-Pseudomonas aeruginosa effects in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}